PillRx only · Tablet, Film Coated · Oral
Estrogens, Conjugated
Brands: Conjugated Estrogens · Premarin · Estrogens, Conjugated
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 18 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$6.213
Latest avg · Jul 22, 2026
-11%
Since Jan 1, 2026
4
Active US suppliers
71%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
25K
Rx · 2026 Q1
961K
Units dispensed
-28%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | unknown | 10 | SUPPLYING |
| Ingenus Pharmaceuticals, LLC | unknown | 10 | SUPPLYING |
| Prasco Laboratories | unknown | 5 | SUPPLYING |
| A-S Medication Solutions | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 15, 2016RECALLRecall (Class III): PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals…
Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17. — Recalling firm: Pfizer Inc. — Nationwide